NO973081D0 - Fremgangmåte for behandling av kroniske progressive vaskulære sykdommer - Google Patents

Fremgangmåte for behandling av kroniske progressive vaskulære sykdommer

Info

Publication number
NO973081D0
NO973081D0 NO973081A NO973081A NO973081D0 NO 973081 D0 NO973081 D0 NO 973081D0 NO 973081 A NO973081 A NO 973081A NO 973081 A NO973081 A NO 973081A NO 973081 D0 NO973081 D0 NO 973081D0
Authority
NO
Norway
Prior art keywords
procedure
treatment
vascular diseases
chronic progressive
progressive vascular
Prior art date
Application number
NO973081A
Other languages
English (en)
Other versions
NO313686B1 (no
NO973081L (no
Inventor
Gary E Striker
Liliane J Striker
Fred P Sherman
Original Assignee
Baker Norton Pharma
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baker Norton Pharma, Us Health filed Critical Baker Norton Pharma
Publication of NO973081D0 publication Critical patent/NO973081D0/no
Publication of NO973081L publication Critical patent/NO973081L/no
Publication of NO313686B1 publication Critical patent/NO313686B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
NO19973081A 1995-06-07 1997-07-02 Anvendelse av pentosanpolysulfat (PPS) for behandling av kroniske progressive vaskul¶re sykdommer NO313686B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/478,347 US5643892A (en) 1995-06-07 1995-06-07 Method of treating chronic progressive vascular diseases
PCT/US1996/008367 WO1996040158A1 (en) 1995-06-07 1996-06-03 Method of treating chronic progressive vascular diseases
BR9704114-9A BR9704114A (pt) 1995-06-07 1997-07-28 Processo de tratamento de doenças vasculares progressivas crÈnicas

Publications (3)

Publication Number Publication Date
NO973081D0 true NO973081D0 (no) 1997-07-02
NO973081L NO973081L (no) 1997-08-27
NO313686B1 NO313686B1 (no) 2002-11-18

Family

ID=25664870

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19973081A NO313686B1 (no) 1995-06-07 1997-07-02 Anvendelse av pentosanpolysulfat (PPS) for behandling av kroniske progressive vaskul¶re sykdommer

Country Status (14)

Country Link
US (1) US5643892A (no)
EP (1) EP0809505B1 (no)
AU (1) AU699012B2 (no)
BR (1) BR9704114A (no)
CA (1) CA2210351C (no)
DE (1) DE809505T1 (no)
ES (1) ES2115571T3 (no)
HU (1) HUP9802431A3 (no)
IL (1) IL121217A (no)
NO (1) NO313686B1 (no)
NZ (1) NZ309991A (no)
TW (1) TW434018B (no)
WO (1) WO1996040158A1 (no)
ZA (1) ZA964247B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010005720A1 (en) * 1995-06-07 2001-06-28 U.S.A. As Represented By The Secretary Department Of Health And Human Services Method of treating chronic progressive vascular scarring diseases
US6255295B1 (en) 1996-12-23 2001-07-03 Nutramax Laboratories, Inc. Aminosugar, glycosaminoglycan or glycosaminoglycan-like compounds, and s-adenosylmethionine composition for the protection, treatment, repair, and reduction of inflammation of connective tissue
UA65587C2 (en) * 1997-10-09 2004-04-15 Baker Norton Pharma Method for preventing nephrotoxicity induced by cyclosporins or tacrolimus
DE19747195A1 (de) * 1997-10-24 1999-04-29 Knoll Ag Verwendung von Glykosaminoglykanen zur Herstellung von pharmazeutischen Zubereitungen zur Behandlung von mit Diabetes assoziierten Augenkrankheiten
US20020010140A1 (en) 2000-01-19 2002-01-24 Striker Gary E. Use of pentosan polysulfate to treat certain conditions of the prostate
CA2616230A1 (en) * 2005-07-22 2007-02-01 Trf Pharma, Inc. Method for treating sickle cell disease and sickle cell disease sequelae
DK2010220T3 (da) * 2006-04-03 2022-05-23 Ceva Animal Health Pty Ltd Stabiliserede pentosanpolysulfat-(pps)-formuleringer
US9339524B2 (en) 2009-03-11 2016-05-17 Jellice Co., Ltd. Drug inhibiting the progression of atherosclerosis, preventive drug, blood cholesterol-lowering drug, functional food, and specific health food
WO2011088418A2 (en) * 2010-01-15 2011-07-21 Mount Sinai School Of Medicine Inhibition of tnf-alpha induced activation of nfkb by pentosan polysulfate
ES2664844T3 (es) 2011-06-20 2018-04-23 Mount Sinai School Of Medicine Tratamiento dirigido contra TNF para las mucopolisacaridosis y otros trastornos lisosómicos
US20130273096A1 (en) * 2011-10-05 2013-10-17 Bruce A. Daniels Therapeutic Sulfated Polysaccharides, Compositions Thereof, and Methods for Treating Patients
US20210186883A1 (en) 2018-08-20 2021-06-24 Reqmed Company, Ltd. Novel pentosan polysulfate sodium preparation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820693A (en) * 1986-05-22 1989-04-11 Angiogenics, Ltd. Method and composition for arresting angiogenesis and capillary, cell or membrane leakage
US4966890A (en) * 1986-04-04 1990-10-30 Angiogenics, Ltd. Method and composition for arresting angiogenesis and capillary, cell or membrane leakage
DE3725554A1 (de) * 1987-08-01 1989-02-09 Hoechst Ag Pharmazeutisches kombinationspraeparat sowie dessen herstellung und verwendung
US5032679A (en) * 1988-12-15 1991-07-16 Glycomed, Inc. Heparin fragments as inhibitors of smooth muscle cell proliferation
EP0466315A3 (en) * 1990-05-30 1992-07-01 Larrian Gillespie Compositions containing xylan sulphates for affecting growth factor function and for inhibiting fibroblast proliferation
US5605938A (en) * 1991-05-31 1997-02-25 Gliatech, Inc. Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate

Also Published As

Publication number Publication date
CA2210351C (en) 2003-09-23
NO313686B1 (no) 2002-11-18
NZ309991A (en) 2001-03-30
ES2115571T3 (es) 2003-09-01
AU6030096A (en) 1996-12-30
CA2210351A1 (en) 1996-12-19
NO973081L (no) 1997-08-27
ZA964247B (en) 1996-12-04
TW434018B (en) 2001-05-16
US5643892A (en) 1997-07-01
IL121217A (en) 2000-09-28
EP0809505A1 (en) 1997-12-03
EP0809505B1 (en) 2003-04-02
DE809505T1 (de) 1998-05-28
HUP9802431A2 (hu) 1999-02-01
IL121217A0 (en) 1999-10-28
ES2115571T1 (es) 1998-07-01
HUP9802431A3 (en) 2001-06-28
WO1996040158A1 (en) 1996-12-19
EP0809505A4 (en) 1998-07-01
BR9704114A (pt) 2000-06-06
AU699012B2 (en) 1998-11-19

Similar Documents

Publication Publication Date Title
NO976063D0 (no) Fremgangsmåte for behandling av diabetes
DK0730864T3 (da) Lægemiddel til behandling af inflammatoriske hjertesygdomme
NO965377L (no) Indolinonforbindelser for behandling av sykdommer
NO924461D0 (no) Dipyridamol for behandling av proliferaktive sykdommer
NO982172D0 (no) Anvendelse av epinastin for behandling av smerter
NO20010882D0 (no) Terapier for behandling av lungesykdommer
NO961483L (no) Fremgangsmåte for behandling av oljeholdig formasjon
FI952169A (fi) Stabiili valmiste veren koagulaatiohäiriöiden hoitamiseksi
ATE201992T1 (de) Carbostyrilderivat zur behandlung von ophthalmologischen erkrankungen
ITTO940748A0 (it) Condotto protesico particolarmente per il trattamento di patologie cardiovascolari.
NO973081D0 (no) Fremgangmåte for behandling av kroniske progressive vaskulære sykdommer
DE69620691D1 (de) Therapeutisches Mittel zur Behandlung der Hypercholesterinämie
ZA968990B (en) Pharmaceutical agents for the treatment of acute and chronic inflammatory diseases.
EE9700235A (et) Benseenamiidid neurodegeneratiivsete haiguste ravimiseks
NO973531D0 (no) Anvendelse av melatonin for behandling av pasienter som lider av medikamentavhengighet
ITMI950532A0 (it) Derivato di aminotetralina per la terapia di malattie cardiovascolari
NO973366D0 (no) Fremgangsmåte for behandling av multippel sklerose
NO913117L (no) Fremgangsmaate for behandling av benoedeleggende sykdommer.
NO981822D0 (no) Anvendelse av proteinet GAX for behandling av cancer
NO982562D0 (no) Sammensetning for behandling av smerte
NO20002481D0 (no) Kombinasjonsterapi for behandling av AIDS
ZA944671B (en) Medicaments for the treatment of inflammatory diseases
NO952526D0 (no) Metoder for behandling av reumatisme
NO962812D0 (no) Fremgangsmåte for behandling av nervebetennelse
NO984190D0 (no) Fremgangsmåte for behandling av insomnia